In order to promote liver disease related research at KUMC, the Phase III COBRE proposes to institute an annual Pilot Grants Program. The goals of this Pilot Grants Program are to support the career development of new investigators, allow established investigators to enter a new field, and promote collaborative interactions among the faculty. The topics supported will cover the broad area of liver diseases including basic, translational and clinical investigation. To achieve these goals we propose three specific aims: 1. To establish a Pilot Grants Program to fund promising new investigators in the area of liver disease research. 2. To have the Pilot Grants Program serve as a means to enhance communication and increase collaboration within the liver research community, between basic and clinical investigators, and between KUMC and KU Lawrence investigators, and 3. To assess the impact of the Pilot Grants Program on the grant recipients and the Liver Research Community at KU, and to use this information to modify and improve the program. We will further use this information to improve the Pilot Grants Program through a process of re-evaluation of practices and program modification. Our plan will be to award three $40,000 grants in the first year and then a combination of new and second year grants eventually for a total of five awards per year. We will introduce several innovative aspects of this Pilot Grants Program including an annual symposium in which the applicants propose their research to the broader liver research community, and an evaluation process in which the impact of the Pilot Grants Program on career development will be assessed. This program is expected to help grow the critical mass in NIH-funded liver disease research and position us to successfully compete for center funding at the completion of this award period.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
1P30GM118247-01
Application #
9073981
Study Section
Special Emphasis Panel (ZGM1-RCB-3 (C3))
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$202,290
Indirect Cost
$70,074
Name
University of Kansas
Department
Type
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Li, Jibiao; Woolbright, Benjamin L; Zhao, Wen et al. (2018) Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice. Toxicol Sci 161:34-47
Woolbright, Benjamin L; Jaeschke, Hartmut (2018) Mechanisms of Inflammatory Liver Injury and Drug-Induced Hepatotoxicity. Curr Pharmacol Rep 4:346-357
Zou, An; Magee, Nancy; Deng, Fengyan et al. (2018) Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. J Biol Chem 293:8656-8671
Ramachandran, Anup; Jaeschke, Hartmut (2018) Acetaminophen Toxicity: Novel Insights Into Mechanisms and Future Perspectives. Gene Expr 18:19-30
Ramachandran, Anup; Jaeschke, Hartmut (2018) Oxidative Stress and Acute Hepatic Injury. Curr Opin Toxicol 7:17-21
Li, Yuan; Chao, Xiaojuan; Yang, Li et al. (2018) Impaired Fasting-Induced Adaptive Lipid Droplet Biogenesis in Liver-Specific Atg5-Deficient Mouse Liver Is Mediated by Persistent Nuclear Factor-Like 2 Activation. Am J Pathol 188:1833-1846
McGill, Mitchell R; Jaeschke, Hartmut (2018) Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation. Expert Rev Mol Diagn 18:797-807
Huck, Ian; Beggs, Kevin; Apte, Udayan (2018) Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet-Induced Hepatic Steatosis in Mice. Int J Toxicol 37:383-392
Jiang, Lu; Fang, Pingping; Septer, Seth et al. (2018) Inhibition of Mast Cell Degranulation With Cromolyn Sodium Exhibits Organ-Specific Effects in Polycystic Kidney (PCK) Rats. Int J Toxicol 37:308-326
Wang, Yifeng; Ding, Wen-Xing; Li, Tiangang (2018) Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. Biochim Biophys Acta Mol Cell Biol Lipids 1863:726-733

Showing the most recent 10 out of 65 publications